Johnson & Johnson Fails to Overturn Talcum Powder Cancer Verdict
- Court upholds $45 million mesothelioma verdict against Johnson & Johnson
- Jury verdict stands despite Johnson & Johnson’s request for a new trial
- Laboratory testing revealed asbestos in Johnson’s Baby Powder
- Theresa Garcia’s children file the lawsuit
A Circuit Court in Cook County, Illinois has denied Johnson & Johnson’s request for a new trial in a mesothelioma lawsuit, upholding the $45 million verdict. The company had raised multiple issues but failed to substantially prejudice the jury. Theresa Garcia’s children, represented by Dean Omar Branham Shirley LLP, expressed satisfaction with the decision. Laboratory testing revealed asbestos in Johnson’s Baby Powder samples. The firm states that J&J deceived customers about its talc-based product.
Factuality Level: 8
Factuality Justification: The article provides accurate and relevant information about the court’s decision in a mesothelioma lawsuit involving Johnson & Johnson and includes quotes from the representing lawyer. It also mentions the jury verdict and laboratory testing results. However, it contains some subjective statements like ‘Johnson & Johnson deceived its customers for years rather than owning up to its negligence’ which could be considered as personal perspective.
Noise Level: 2
Noise Justification: The article provides relevant and factual information about a court decision in a mesothelioma lawsuit against Johnson & Johnson, with no apparent noise or filler content. It also holds the company accountable for its actions and includes evidence of asbestos presence in their product. The reporting is not exaggerated and stays on topic without diving into unrelated territories.
Public Companies: Johnson & Johnson (JNJ)
Private Companies: Dean Omar Branham Shirley, LLP,Cyprus Amax Minerals Company
Key People: Trey Branham (Partner at Dean Omar Branham Shirley, LLP), Jessica Dean (Partner at Dean Omar Branham Shirley, LLP), Patrick J. Sherlock (Judge)
Financial Relevance: Yes
Financial Markets Impacted: Yes
Financial Rating Justification: The article discusses a court decision in a mesothelioma lawsuit against Johnson & Johnson (JNJ), which has financial relevance as it is a company listed on the NYSE. The outcome of this case may impact the company’s reputation and potentially its stock price, affecting investors and financial markets.
Presence Of Extreme Event: No
Nature Of Extreme Event: No
Impact Rating Of The Extreme Event: No
Extreme Rating Justification: There is no extreme event mentioned in the text and it’s not the main topic.
Move Size: No market move size mentioned.
Sector: Healthcare
Direction: Down
Magnitude: Large
Affected Instruments: Stocks
www.businesswire.com 
